IFNA1 and glioblastoma: Both GSCs and GBM tumors showed high IFN signaling in mesenchymal subtypes, which might be due to continuous exposure to cytokines and IFNs secreted by tumor cells and/or infiltrating nontumor cells or immune cells within the TME.